News & Events

• October 21, 2019
  

  Towards EMA Qualification of Islet Auto-Antibodies as a Model-Based Clinical Trial Enrichment Platform for Type-1 Diabetes Prevention Studies

• September 23, 2019
  Enabling efficient use of digital health technologies to support Parkinson’s disease drug development through precompetitive collaboration

• July 14, 2019 - July 18, 2019
  

  Poster Presentation at the 2019 Alzheimer’s Association International Conference, July 14-18, 2019, Los Angeles, CA

  The Alzheimer’s Association International Conference (AAIC) is an important annual scientific meeting where international investigators, clinicians and care providers gather to share the latest study results, theories and discoveries that will help bring the world closer to breakthroughs in dementia science. This year’s conference will be hosted in Los Angeles, CA, between July 14th and 18th.

  Each year, on behalf of our consortium members, CPAD attends AAIC to share the consortium’s vision, goals, and latest milestones of our work with the research community, to educate ourselves on latest developments and trends, and to meet and exchange information with our members and other key opinion leaders. This year, one poster (P4-253) was accepted for presentation.

• June 25, 2019
  Best Practices for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials

• June 3, 2019
  Collaborative framework for delivering on ways that digital technologies can help to optimize new Parkinson’s treatment trials. Stephenson D …et al. | 5th World Parkinson Congress, Kyoto, Japan